Evaluate the Ability of Systane Ultra to Improve Subjective Symptoms of Ocular Irritation Post 60 Min. Athletic Performance.

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00938951

Enrollment

Registered

2009-07-14

Start date

2009-06-30

Completion date

Unknown

Last updated

2012-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye Symptoms, Visual Performance

Keywords

Dry Eye, Visual Performance

Brief summary

The primary objective of this study is to compare visual degradation in a stressed (forced stare) environment in patients before and after acute administration of Systane Ultra.

Interventions

OTHERSystane® Ultra

Polyethylene Glycol 400 0.4% / Propylene Glycol 0.3%

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Player/ Coach must answer Yes to the survey eligibility question. * Player/Coach must voluntarily agree to participate in survey

Exclusion criteria

* None.

Design outcomes

Primary

Measure	Time frame
Effectiveness of eye drop basd on athlete's opinion/experience during a one hour practice session	60 minutes post-dosing with test article

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026